source
- FDA approves brexu-cel for adult relapsed/refractory mantle cell lymphomaThe U.S. Food and Drug Administration has granted approval for brexu-cel as a treatment option for adult patients with relapsed or refractory mantle cell lymphoma. Dr. Luhua (Michael) Wang discuss…
- FDA grants accelerated approval to sonrotoclax for relapsed/refractory mantle cell lymphomaThe U.S. Food and Drug Administration has granted accelerated approval to sonrotoclax (brand name Beqalzi) for adult patients with relapsed or refractory mantle cell lymphoma who have received at l…